Sansure Biotech Inc. (688289.SS)

18,20 +0,06 (+0,33 %) À partir de 01:18PM CST. Marché ouvert.

Sansure Biotech Inc.

No. 680, Lusong Road
High-tech Industrial Development Zone
Changsha 410205
China
86 731 8888 3176
https://www.sansure.com.cn

Secteur(s): Healthcare
Secteur d’activité: Medical Instruments & Supplies
Employés à temps plein: 2 006

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Lizhong Dai	Chairman of the Board & GM	S.O.	S.O.	1968
Mr. Peng Zhu	CFO, Deputy GM, Board Secretary & Director	S.O.	S.O.	1975
Mr. Xialin Yu	Deputy GM & Director	S.O.	S.O.	1979
Mr. Xu Fan	Deputy GM & Director	S.O.	S.O.	1981
Mr. Jia Liu	Deputy GM & Director	S.O.	S.O.	1982
Mr. Zhongping Deng	Deputy General Manager	S.O.	S.O.	1977
Ms. Jun Zhou	Deputy General Manager	S.O.	S.O.	1971
Mr. Liu Kai	Deputy General Manager	S.O.	S.O.	1977
Mr. Jian Zhu	Deputy General Manager	S.O.	S.O.	1976
Mr. Haixiao Wang	Deputy General Manager	S.O.	S.O.	1978

Les montants ont été établis en date du et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en CNY.

Description

Sansure Biotech Inc. engages in the research and development, production, and sale of in vitro diagnostic reagents and instruments in China. It offers nucleic acid and multiple nucleic acid diagnostic kits for coronavirus, CoV-2, influenza virus, and respiratory syncytial virus; DNA fluorescence and nucleic acid diagnostic kits for respiratory tract infections, HPV infections, and reproductive tract infections; nucleic acid tests and fluorescence diagnostic kits for blood-borne infections; RNA diagnostic kits for gastrointestinal infections; and diagnostic kits for monkeypox, epstein-barr virus, and human cytomegalovirus DNA, as well as rapid antigen tests. The company also provides nucleic acid extraction or purification kits, multi-type sample DNA/RNA extraction-purification kits, and sample release reagents; sample storage reagents for SARS-CoV-2; extraction instruments and systems; and PCR instruments comprising real-time quantitative thermal cyclers, portable molecule workstations, and real-time PCR systems. In addition, it engages in the research and development, production, and sale of drugs; procurement and sale of raw materials; manufacture of instruments; manufacture and sale of electronic equipment; trading; investment advisory; medical research and experimental development; and internet sales, as well as offers third-party medical testing and biotechnology development services. The company was founded in 2008 and is headquartered in Changsha, China.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Sansure Biotech Inc. en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.